{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-028003","form_type":"8-K","ticker":"CTXR","cik":"0001506251","company_name":"Citius Pharmaceuticals, Inc.","filed_at":"2025-04-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.522809+00:00","generated_at":"2026-05-23T23:33:56.419006+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Citius Pharma raises $2M in registered direct offering; proceeds for LYMPHIR launch","bullets":["Offering of 465,000 shares at $1.15 and 1,274,131 pre-funded warrants at $1.1499.","Net proceeds ~$1.735M after fees; used for commercial launch of LYMPHIR and general corporate purposes.","Placement agent H.C. Wainwright received 7% cash fee and 121,739 warrants exercisable at $1.4375.","Company agreed to 30-day lock-up on further equity issuances."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-028003","json":"https://secwatch.observer/filing/0001213900-25-028003.json","markdown":"https://secwatch.observer/filing/0001213900-25-028003.md","text":"https://secwatch.observer/filing/0001213900-25-028003.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1506251/000121390025028003/0001213900-25-028003-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1506251/000121390025028003/ea0236661-8k_citius.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T23:33:56.419006+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}